{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:39:20Z","timestamp":1791549560685,"version":"4.3.4"},"reference-count":66,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The increased popularity and ubiquitous use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of diabetes, heart failure, and obesity has led to significant concern for increased risk for perioperative aspiration, given their effects on delayed gastric emptying. This concern is highlighted by many major societies that have published varying guidance on the perioperative management of these medications, given limited data. We conducted a scoping review of the available literature regarding the aspiration risk and aspiration\/regurgitant events related to GLP-1 RAs. Methods: A librarian-assisted search was performed using five electronic medical databases (PubMed, Embase, and Web of Science Platform Databases, including Web of Science Core Collection, KCI Korean Journal Database, MEDLINE, and Preprint Citation Index) from inception through March 2024 for articles that reported endoscopic, ultrasound, and nasogastric evaluation for increased residual gastric volume retained food contents, as well as incidences of regurgitation and aspiration events. Two reviewers independently screened titles, abstracts, and full text of articles to determine eligibility. Data extraction was performed using customized fields established a priori within a systematic review software system. Results: Of the 3712 citations identified, 24 studies met eligibility criteria. Studies included four prospective, six retrospective, five case series, and nine case reports. The GLP-1 RAs reported in the studies included semaglutide, liraglutide, lixisenatide, dulaglutide, tirzepatide, and exenatide. All studies, except one case report, reported patients with confounding factors for retained gastric contents and aspiration, such as a history of diabetes, cirrhosis, hypothyroidism, psychiatric disorders, gastric reflux, Barrett\u2019s esophagus, Parkinson\u2019s disease, dysphagia, obstructive sleep apnea, gastric polyps, prior abdominal surgeries, autoimmune diseases, pain, ASA physical status classification, procedural factors (i.e., thyroid surgery associated with risk for nausea, ketamine associated with nausea and secretions), and\/or medications associated with delayed gastric emptying (opioids, anticholinergics, antidepressants, beta-blockers, calcium channel blockers, DPP-IV inhibitors, and antacids). Of the eight studies (three prospective and five retrospective) that evaluated residual contents in both GLP-1 users and non-users, seven studies (n = 7\/8) reported a significant increase in residual gastric contents in GLP-1 users compared to non-users (19\u201356% vs. 5\u201320%). In the three retrospective studies that evaluated for aspiration events, there was no significant difference in aspiration events, with one study reporting aspiration rates of 4.8 cases per 10,000 in GLP-1 RA users compared to 4.6 cases per 10,000 in nonusers and the remaining two studies reporting one aspiration event in the GLP-1 RA user group and none in the non-user group. In one study that evaluated for regurgitation or reflux by esophageal manometry and pH, there was no significant difference in reflux episodes but a reduction in gastric acidity in the GLP-1 RA user group compared to the non-user group. Conclusions: There is significant variability in the findings reported in the studies, and most of these studies include confounding factors that may influence the association between GLP-1 RAs and an increased risk of aspiration and related events. While GLP-1 RAs do increase residual gastric contents in line with their mechanism of action, the currently available data do not suggest a significant increase in aspiration and regurgitation events associated with their use and the withholding of GLP-1 RAs to reduce aspiration and regurgitation events, as is currently recommended by many major societal guidelines. Large randomized controlled trials (RCTs) may be helpful in further elucidating the impact of GLP-1 RAs on perioperative aspiration risk.<\/jats:p>","DOI":"10.3390\/jcm13216336","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T06:00:52Z","timestamp":1729663252000},"page":"6336","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-2612","authenticated-orcid":false,"given":"Marvin G.","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-9774","authenticated-orcid":false,"given":"Juan G.","family":"Ripoll","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-0098","authenticated-orcid":false,"given":"Ernesto","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Bittner","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamacardio.2020.1966","article-title":"Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular Disease: A Review","volume":"5","author":"Honigberg","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgad398","article-title":"Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure","volume":"109","author":"Ferreira","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: Cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Popoviciu, M.S., Paduraru, L., Yahya, G., Metwally, K., and Cavalu, S. (2023). Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310449"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: A randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"Birkenfeld","year":"2018","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ferhatbegovic, L., Mrsic, D., and Macic-Dzankovic, A. (2023). The benefits of GLP1 receptors in cardiovascular diseases. Front. Clin. Diabetes Healthc., 4.","DOI":"10.3389\/fcdhc.2023.1293926"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12630-023-02550-y","article-title":"Anesthesia and glucagon-like peptide-1 receptor agonists: Proceed with caution!","volume":"70","author":"Jones","year":"2023","journal-title":"Can. J. Anesth."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/anae.16099","article-title":"Aspiration risk with glucagon-like peptide 1 (GLP-1) agonists","volume":"78","author":"Olesnicky","year":"2023","journal-title":"Anaesthesia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.21037\/apm-20-2382","article-title":"Perioperative pulmonary aspiration and regurgitation without aspiration in adults: A retrospective observational study of 166,491 anesthesia records","volume":"10","author":"Sun","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/bjaceaccp\/mkt053","article-title":"Aspiration under anaesthesia: Risk assessment and decision-making","volume":"14","author":"Robinson","year":"2013","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ALN.0000000000003831","article-title":"Pulmonary Aspiration of Gastric Contents: A Closed Claims Analysis","volume":"135","author":"Warner","year":"2021","journal-title":"Anesthesiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12630-024-02810-5","article-title":"Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: Implications for clinical practice and future investigations","volume":"71","author":"Chang","year":"2024","journal-title":"Can. J. Anaesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc22-S016","article-title":"16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_16","unstructured":"Australian and New Zealand College of Anaesthetists (2024, January 05). Surgery Warning on Use of Popular Weight Loss Drugs. Available online: https:\/\/www.anzca.edu.au\/resources\/media-releases\/2023-media-releases\/gastric-emptying-mr.pdf."},{"key":"ref_17","unstructured":"Australian Diabetes Society (ADS) and the Australian and New Zealand College of Anaesthetists & Faculty of Pain Medicine (ANZCA) (2024, January 05). ADS-ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (Adults). Updated November 2022., Available online: https:\/\/www.diabetessociety.com.au\/wp-content\/uploads\/2023\/03\/ADS-ANZCA-Perioperative-Diabetes-and-Hyperglycaemia-Guidelines-Adults-November-2022-v2-Final.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr. Pract."},{"key":"ref_19","unstructured":"Canadian Anesthesiolgists\u2019 Society (2024, January 05). Canadian Anesthesiologists\u2019 Society Medication Safety Bulletin. Available online: https:\/\/www.cas.ca\/CASAssets\/Documents\/Advocacy\/Semaglutide-bulletin_final.pdf."},{"key":"ref_20","unstructured":"Centre for Perioperative Care (2024, January 05). Guideline for Perioperative Care for People with Diabetes Mellitus Undergoing Elective and Emergency Surgery. Available online: https:\/\/www.cpoc.org.uk\/sites\/cpoc\/files\/documents\/2021-03\/CPOC-Guideline%20for%20Perioperative%20Care%20for%20People%20with%20Diabetes%20Mellitus%20Undergoing%20Elective%20and%20Emergency%20Surgery.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"NHS Diabetes guideline for the perioperative management of the adult patient with diabetes","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication","volume":"22","author":"Hashash","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_23","unstructured":"Joshi, G.P., Abdelmalak, B.B., Weigel, W.A., Soriano, S.G., Harbell, M.W., Kuo, K.I., Stricker, P.A., Domino, K.B., and American Society of Anesthesiologists (ASA) Task Force on Preoperative Fasting (2024, January 05). American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. Available online: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Membership of the Working Party, Barker, P., Creasey, P.E., Dhatariya, K., Levy, N., Lipp, A., Nathanson, M.H., Penfold, N., Watson, B., and Woodcock, T. (2015). Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 70, 1427\u20131440.","DOI":"10.1111\/anae.13233"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/anae.14663","article-title":"Correction","volume":"74","author":"Nathanson","year":"2019","journal-title":"Anaesthesia"},{"key":"ref_26","unstructured":"Olesnicky, B. (2024, January 05). GLP-1 Agonists and Gastric Emptying. Bulletin. Australian and New Zealand College of Anaesthetists (ANZCA) & Faculty of Pain Medicine (FPM); Winter 2023:20. Available online: https:\/\/www.anzca.edu.au\/getattachment\/7a78cb16-7867-4100-8464-265108b091e7\/ANZCA-Bulletin-Winter-2023."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.mayocp.2020.10.002","article-title":"Preoperative Management of Endocrine, Hormonal, and Urologic Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_28","unstructured":"American Association of Nurse Anesthesiology (2024, March 28). Anesthesia Care of the Patient on a GLP-1 Receptor Agonist. Available online: https:\/\/issuu.com\/aanapublishing\/docs\/anesthesia_care_of_the_patient_on_a_glp-1_receptor?fr=sNzJkODcwOTA0NDQ."},{"key":"ref_29","unstructured":"Institute for Safe Medication Practices Canada (2024, March 28). Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Risk of Aspiration during Anesthesia. ISMP Canada Safety Bulletin. Available online: https:\/\/ismpcanada.ca\/wp-content\/uploads\/ISMPCSB2023-i9-GLP-1.pdf."},{"key":"ref_30","first-page":"32","article-title":"Evidence-based clinical practice manual: Patient preparation for surgery and transfer to the operating room","volume":"43","author":"Escobar","year":"2015","journal-title":"Colomb. J. Anesthesiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: An analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Inf. Libr. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2337\/dc20-0720","article-title":"Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients with Type 2 Diabetes","volume":"43","author":"Quast","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: A prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can. J. Anaesth."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2023.11.024","article-title":"Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist","volume":"22","author":"Anazco","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s10620-020-06718-0","article-title":"Food Residue During Esophagogastroduodenoscopy Is Commonly Encountered and Is Not Pathognomonic of Delayed Gastric Emptying","volume":"66","author":"Bi","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111091","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J. Clin. Anesth."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: A historical cohort study","volume":"71","author":"Wu","year":"2024","journal-title":"Can. J. Anaesth."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1002\/anr3.12278","article-title":"Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss","volume":"12","author":"Avraham","year":"2024","journal-title":"Anaesth. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23247096211051919","DOI":"10.1177\/23247096211051919","article-title":"Medication-Induced Gastroparesis: A Case Report","volume":"9","author":"Kalas","year":"2021","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e23.00506","DOI":"10.2106\/JBJS.CC.23.00506","article-title":"Retained Gastric Contents After Adequate Fasting Associated with GLP-1 Receptor Agonist Use: A Report of 3 Cases","volume":"13","author":"Kittner","year":"2023","journal-title":"JBJS Case Connect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.amjmed.2023.07.016","article-title":"Delayed Gastric Emptying with Perioperative Use of Glucagon-like Peptide-1 Receptor Agonists","volume":"136","author":"Raven","year":"2023","journal-title":"Am. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e01712","DOI":"10.1213\/XAA.0000000000001712","article-title":"Particulate Gastric Contents in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists After Appropriate Perioperative Fasting: A Report of 2 Cases","volume":"17","author":"Wilson","year":"2023","journal-title":"A A Pract."},{"key":"ref_48","first-page":"e11735","article-title":"Gastroparesis with the Initiation of Liraglutide: A Case Report","volume":"12","author":"Almustanyir","year":"2020","journal-title":"Cureus"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/YCT.0000000000000992","article-title":"Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations","volume":"40","author":"Espinoza","year":"2024","journal-title":"J. ECT"},{"key":"ref_50","first-page":"e42153","article-title":"Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying","volume":"15","author":"Fujino","year":"2023","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e01751","DOI":"10.1213\/XAA.0000000000001751","article-title":"Point-of-Care Gastric Ultrasound to Identify a Full Stomach on a Diabetic Patient Taking a Glucagon-Like Peptide 1 Receptor Agonist","volume":"18","author":"Perlas","year":"2024","journal-title":"A A Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: A case report","volume":"70","author":"Gulak","year":"2023","journal-title":"Can. J. Anaesth."},{"key":"ref_53","first-page":"e26916","article-title":"Suspected Gastroparesis with Concurrent Gastroesophageal Reflux Disease Induced by Low-Dose Liraglutide","volume":"14","author":"Ishihara","year":"2022","journal-title":"Cureus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: A case report","volume":"70","author":"Klein","year":"2023","journal-title":"Can. J. Anaesth."},{"key":"ref_55","first-page":"e3791","article-title":"Liraglutide-induced Acute Gastroparesis","volume":"10","author":"Rai","year":"2018","journal-title":"Cureus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.bja.2023.05.005","article-title":"Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss","volume":"131","author":"Weber","year":"2023","journal-title":"Br. J. Anaesth."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cgh.2017.11.024","article-title":"Incidence of Gastric-to-Pulmonary Aspiration in Patients Undergoing Elective Upper Gastrointestinal Endoscopy","volume":"16","author":"Bohman","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrd1828","article-title":"Exenatide","volume":"4","author":"Davidson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00134-010-1856-y","article-title":"Gastric residual volume during enteral nutrition in ICU patients: The REGANE study","volume":"36","author":"Montejo","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e14340","DOI":"10.1111\/iwj.14340","article-title":"Correlation between blood glucose level and poor wound healing after posterior lumbar interbody fusion in patients with type 2 diabetes","volume":"21","author":"Chen","year":"2024","journal-title":"Int. Wound J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archsurg.2010.179","article-title":"Postoperative hyperglycemia and surgical site infection in general surgery patients","volume":"145","author":"Ata","year":"2010","journal-title":"Arch. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13741-023-00302-6","article-title":"Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery","volume":"12","author":"Sreedharan","year":"2023","journal-title":"Perioper. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/db13-0893","article-title":"Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia","volume":"63","author":"Umapathysivam","year":"2014","journal-title":"Diabetes"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2005-2220","article-title":"Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses","volume":"91","author":"Little","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2003-030049","article-title":"Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes","volume":"88","author":"Meier","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6336\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:18:29Z","timestamp":1760113109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":66,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216336"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216336","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]}}}